We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DPRO
12326
Draganfly
DPRO
$162M
$69K ﹤0.01%
1,690
+162
+11% +$11.5K
ERNA icon
12327
PUT
Eterna Therapeutics
ERNA
$5.53M
$69K ﹤0.01%
2
-7
-78% -$381K
IDN icon
12328
CALL
Intellicheck
IDN
$57.6M
$69K ﹤0.01%
15,000
-65,000
-81% -$447K
LU icon
12329
CALL
Lufax Holding
LU
$1.1B
$69K ﹤0.01%
3,075
-3,950
-56% -$103K
RES icon
12330
CALL
RPC Inc
RES
$1.42B
$69K ﹤0.01%
15,100
-19,800
-57% -$97.2K
SGLY icon
12331
PUT
Singularity Future Technology
SGLY
$8.49M
$69K ﹤0.01%
103
-76
-42% -$35.7K
SOGP
12332
Sound Group
SOGP
$52.1M
$69K ﹤0.01%
3,771
-790
-17% -$20.2K
ORKA
12333
Oruka Therapeutics
ORKA
$6.39B
$69K ﹤0.01%
2,672
-6,498
-71% -$196K
VOLT
12334
PUT
DELISTED
Volt Information Sciences, Inc.
VOLT
$69K ﹤0.01%
23,700
-700
-3% -$2.19K
AMRX icon
12335
Amneal Pharmaceuticals
AMRX
$6.27B
$68K ﹤0.01%
14,287
-604
-4% -$3.01K
PASG icon
12336
PUT
Passage Bio
PASG
$13.9M
$68K ﹤0.01%
+535
New +$87.4K
PLX icon
12337
Protalix BioTherapeutics
PLX
$210M
$68K ﹤0.01%
81,950
-169,221
-67% -$177K
STIM icon
12338
Neuronetics
STIM
$226M
$68K ﹤0.01%
15,350
-29,885
-66% -$146K
CNCE
12339
CALL
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$68K ﹤0.01%
+21,700
New +$72.2K
APRE icon
12340
CALL
Aprea Therapeutics
APRE
$10.8M
$67K ﹤0.01%
+1,170
New +$103K
CKPT
12341
PUT
DELISTED
Checkpoint Therapeutics
CKPT
$67K ﹤0.01%
2,150
-1,270
-37% -$42.1K
CLIR icon
12342
ClearSign Technologies
CLIR
$30.8M
$67K ﹤0.01%
4,846
-1,610
-25% -$26.7K
ELEV
12343
DELISTED
Elevation Oncology
ELEV
$67K ﹤0.01%
+11,201
New +$77.3K
EVAX
12344
Evaxion A/S
EVAX
$26.3M
$67K ﹤0.01%
+302
New +$93.7K
AIXC
12345
CALL
AIxCrypto Holdings Inc
AIXC
$17.1M
$67K ﹤0.01%
126
+106
+530% +$63.7K
REAX icon
12346
Real REMAX Group Inc. Common Stock
REAX
$515M
$67K ﹤0.01%
+1,826
New +$52.1K
SURG icon
12347
SurgePays
SURG
$4.42M
$67K ﹤0.01%
+33,173
New +$85K
MTVA
12348
PUT
MetaVia Inc
MTVA
$10.9M
$67K ﹤0.01%
21
+3
+17% +$13.6K
ALPP
12349
DELISTED
Alpine 4 Holdings Inc
ALPP
$67K ﹤0.01%
+4,343
New +$96.5K
COMS
12350
CALL
DELISTED
COMSovereign Holding Corp. Common Stock
COMS
$67K ﹤0.01%
894
+367
+70% +$43.1K

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.